How many employees does Orexo have this year?
Orexo has 132 undefined employees this year.
Orexo Employees 2025
Orexo Employees
132
Ticker
ORX.ST
ISIN
SE0000736415
WKN
A0HG6G
In 2025, Orexo employed 132 people, a 0% change from the 132 number of employees in the previous year.
Orexo Aktienanalyse
What does Orexo do?
Orexo AB is a Swedish pharmaceutical company that was founded in 1995 and is headquartered in Uppsala. The company focuses on the development of medications for the treatment of pain and addiction disorders. Business model: Orexo's business model is based on the development of innovative medications and their marketing in the global market. The company specializes in the development of medications based on opioid technology. Divisions: Orexo operates in two main business areas: Pharmaceuticals and digital therapeutics. Pharmaceuticals: In the pharmaceutical division, Orexo is primarily involved in the development of medications used in the treatment of pain and addiction disorders. Some of the best-known medications include: - Zubsolv: a medication for the treatment of opioid addiction - Abstral: a fast-acting pain medication for cancer patients - Edluar: a sleep medication for the treatment of sleep disorders Orexo's pharmaceuticals are distributed in over 60 countries worldwide and have already helped many patients alleviate their symptoms. Digital therapeutics: Orexo has expanded its business model and offers digital therapeutics - apps that contribute to improving the success of pain and addiction disorder treatment. One example is the app "Orexo Digital," which helps patients better monitor their medication and document the progress of their treatment. The app is free and can be downloaded by patients who have been prescribed medications from Orexo. History: Orexo was founded in 1995 by a team of researchers from Uppsala University. The company initially focused on the development of medications for the treatment of inflammatory diseases and allergies. In 2003, the company decided to concentrate on the development of medications in pain and addiction treatment. The first products in this area were the pain medication Abstral and the substitution medication Zubsolv. In the following years, the company grew rapidly and opened additional locations in the United States, United Kingdom, and France. Orexo works closely with key players in the healthcare sector to ensure that its medications are accessible to patients worldwide. Products: Abstral: a medication for the treatment of acute and chronic severe pain. It is taken sublingually and acts quickly. Zubsolv: a medication for the treatment of opioid addiction. It contains the active ingredients buprenorphine and naloxone and can alleviate withdrawal symptoms in opioid addiction. Edluar: a sleep medication for the treatment of sleep disorders. It contains the active ingredient zolpidem and is taken sublingually. Orexo Digital: an app to support patients in the treatment of pain and addiction disorders. It enables the monitoring of treatment progress and provides helpful advice for improving treatment success. Conclusion: Orexo is an innovative pharmaceutical company specializing in the development of medications for the treatment of pain and addiction disorders. The company has made a name for itself with its unique opioid technology and offers successful products such as Abstral and Zubsolv. With its expansion into the field of digital therapeutics, Orexo also demonstrates that it remains at the forefront of technology and innovation. Orexo ist eines der beliebtesten Unternehmen auf Eulerpool.com.Employees Details
Examining Orexo's Employee Base
Orexo's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Orexo's operational capacity and future potential.
Year-to-Year Comparison
Assessing Orexo's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.
Impact on Investments
Orexo's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.
Interpreting Employee Trends
Fluctuations in Orexo’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.
Frequently Asked Questions about Orexo stock
How many employees did Orexo have compared to the previous year?
Compared to the previous year, Orexo had 0% more employees.
What impact did the number of employees have on the company Orexo?
The number of employees has a direct impact on the efficiency and productivity of Orexo. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.
What impact did the number of employees have on investors of Orexo?
The number of employees can also have an impact on investors of Orexo, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.
How does an increase in equity capital of Orexo affect the company?
An increase in equity of Orexo can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.
How does a reduction in Orexo's equity affect the company?
A reduction in equity of Orexo can impair its financial stability and decrease its ability to fulfill future investments and obligations.
What are some factors that influence the equity of Orexo?
Some factors that can influence the equity of Orexo include, among others, revenue development, profit and loss statement, dividend payments, and investments.
Why is the equity of Orexo so important for investors?
The equity of Orexo is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.
How does the number of employees at Orexo influence the company?
The number of employees at Orexo can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.
How has the number of employees at Orexo evolved in recent years?
In recent years, the number of employees at Orexo has changed by 0.
How many employees does Orexo currently have?
Orexo currently has 132 undefined employees.
Why is the number of employees important for investors of Orexo?
The number of employees is important for investors of Orexo as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.
What strategic measures can Orexo take to change the number of employees?
To change the number of employees, Orexo can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.
How much dividend does Orexo pay?
Over the past 12 months, Orexo paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Orexo is expected to pay a dividend of 0 SEK.
What is the dividend yield of Orexo?
The current dividend yield of Orexo is .
When does Orexo pay dividends?
Orexo pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Orexo?
Orexo paid dividends every year for the past 0 years.
What is the dividend of Orexo?
For the upcoming 12 months, dividends amounting to 0 SEK are expected. This corresponds to a dividend yield of 0 %.
In which sector is Orexo located?
Orexo is assigned to the 'Health' sector.
Wann musste ich die Aktien von Orexo kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Orexo from 8/20/2025 amounting to 0 SEK, you needed to have the stock in your portfolio before the ex-date on 8/20/2025.
When did Orexo pay the last dividend?
The last dividend was paid out on 8/20/2025.
What was the dividend of Orexo in the year 2024?
In the year 2024, Orexo distributed 0 SEK as dividends.
In which currency does Orexo pay out the dividend?
The dividends of Orexo are distributed in SEK.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Orexo
Our stock analysis for Orexo Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orexo Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
